Article Text

Download PDFPDF

Protocol
Vitamin D and/or calcium to prevent fractures and falls: protocol for a systematic review and meta-analysis
  1. Olivier Massé1,
  2. Claudia Mei Mercurio1,
  3. Sébastien Dupuis1,
  4. Alexandra Arruda1,
  5. Katherine Desforges2,3,
  6. Nicolas Dugré1,3,
  7. Gabriel Dallaire1,
  8. David Williamson1,4
  1. 1Department of pharmacy, Hôpital du Sacré-Coeur-de-Montréal, Montréal, Québec, Canada
  2. 2Department of pharmacy, McGill University Health Centre, Montréal, Québec, Canada
  3. 3Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada
  4. 4Research Centre, Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’île-de-Montréal, Montréal, Québec, Canada
  1. Correspondence to Olivier Massé; olivier.masse.cnmtl{at}ssss.gouv.qc.ca

Abstract

Background Previous systematic reviews on fracture and fall prevention have generally shown no efficacy with calcium or vitamin D alone and conflicting findings with that of vitamin D combined with calcium. Despite these findings, increases in vitamin D and calcium prescriptions have been reported in many countries, as many clinicians, guidelines and regulatory agencies still largely recommend universal supplementation to adults.

Methods and analysis We will conduct a systematic review of randomised controlled trials on the efficacy of vitamin D and/or calcium in fracture and fall prevention. A systematic search will be performed in Medline, Embase, CENTRAL, International Clinical Trials Registry Platform and Clinicaltrials.gov (1 January 2024). We will also hand search abstracts published in relevant congress and journals (2021–2023) and the reference lists of included trials. We will consider any trial involving the pharmacological administration of calcium alone, vitamin D alone or vitamin D combined with calcium against placebo or no treatment in adults. The primary outcome will be the number of participants with fractures at any site. The secondary outcomes will be the number of participants with hip fractures, non-vertebral fractures, vertebral fractures and falls, and the rate of falls. Two reviewers will independently screen and include the trials, extract the data and assess the risk of bias using the second version of the Cochrane risk-of-bias tool. We plan to pool outcomes to conduct random-effects meta-analyses and to appraise the certainty of evidence using Grading of Recommendations Assessment, Development and Evaluation (GRADE). Many prespecified subgroup and sensitivity analyses will be performed to explore the potential heterogeneity and to test the robustness of our findings.

Ethics and dissemination This systematic review does not require research ethics approval. The results will be disseminated in peer-reviewed journals and help inform clinicians, guidelines and regulatory agencies.

PROSPERO registration number CRD42023483915

  • Calcium & bone
  • Fractures, Closed
  • GERIATRIC MEDICINE
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Conceptualisation: OM. Design and methodology: All authors. Developed the search strategy: OM and DW. Design data extraction: All authors. Pilot data extraction: OM, DW and KD. Drafting the manuscript: OM. Critical revision of the manuscript: All authors. All authors reviewed the content of the protocol and approved the final version. Guarantor of the review: OM.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer-reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.